MUC4-induced nuclear translocation of β-catenin: A novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer

Cancer Letters

Volumn 346, Issue 1, 2014, Pages 104-113

  Zhi, Xiaofei ^a   Tao, Jinqiu ^a   Xie, Kunling ^a   Zhu, Yi ^a   Li, Zheng ^a   Tang, Jie ^a   Wang, Weizhi ^a   Xu, Hao ^a   Zhang, Jingjing ^a   Xu, Zekuan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

MUC4; Pancreatic cancer; WNT pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; HERMES ANTIGEN; MUCIN 4; MYC PROTEIN; PROTEIN TYROSINE KINASE; UVOMORULIN; VASCULOTROPIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CD44 GENE; COMPLEX FORMATION; CYCLIN D1 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; LYSOSOME; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; MUC4 GENE; NONHUMAN; ONCOGENE C MYC; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION; VEGF GENE;

MUC4; PANCREATIC CANCER; WNT PATHWAY;

ANIMALS; BETA CATENIN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; MUCIN-4; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84894626777     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.12.021     Document Type: Article

References (38)

1. Bardeesy N., DePinho R.A. Pancreatic cancer biology and genetics. Nat. Rev. Cancer 2002, 2:897-909.
2. Cao H., LE D., Yang L.X. Current status in chemotherapy for advanced pancreatic adenocarcinoma. Anticancer Res. 2013, 33:1785-1791.
3. Van Den Broeck A., Sergeant G., Ectors N., Van Steenbergen W., Aerts R., Topal B. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur. J. Surg. Oncol. 2009, 35:600-604.
4. Talmadge J.E., Fidler I.J. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010, 70:5649-5669.
5. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 2009, 174:1588-1593.
6. Naumov G.N., Folkman J., Straume O., Akslen L.A. Tumor-vascular interactions and tumor dormancy. APMIS 2008, 116:569-585.
7. Baeriswyl V., Christofori G. The angiogenic switch in carcinogenesis. Semin. Cancer Biol. 2009, 19:329-337.
8. Wilson W.R., Hay M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11:393-410.
9. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
10. Carraway K.L., Theodoropoulos G., Kozloski G.A., Carothers Carraway C.A. Muc4/MUC4 functions and regulation in cancer. Future Oncol. 2009, 5:1631-1640.
11. Zhang J., Zhang X., Zhu Y., Chen Z., Xu Z., Miao Y. Transcriptional regulation of human mucin gene MUC4 in pancreatic cancer cells. Mol. Biol. Rep. 2010, 37:2797-2802.
12. Zhu Y., Zhang J.J., Zhu R., Zhu Y., Liang W.B., Gao W.T., Yu J.B., Xu Z.K., Miao Y. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma. Med. Oncol. 2011, 28:175-184.
13. Chaturvedi P., Singh A.P., Moniaux N., Senapati S., Chakraborty S., Meza J.L., Batra S.K. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol. Cancer Res. 2007, 5:309-320.
14. Singh A.P., Moniaux N., Chauhan S.C., Meza J.L., Batra S.K. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res. 2004, 64:622-630.
15. Ponnusamy M.P., Singh A.P., Jain M., Chakraborty S., Moniaux N., Batra S.K. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br. J. Cancer 2008, 99:520-526.
16. Ponnusamy M.P., Lakshmanan I., Jain M., Das S., Chakraborty S., Dey P., Batra S.K. Oncogene 2010, 29:5741-5754.
17. Bafna S., Kaur S., Momi N., Batra S.K. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br. J. Cancer 2009, 101:1155-1161.
18. Mimeault M., Johansson S.L., Senapati S., Momi N., Chakraborty S., Batra S.K. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Lett. 2010, 295:69-84.
19. Skrypek N., Duchêne B., Hebbar M., Leteurtre E., van Seuningen I., Jonckheere N. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the concentrative nucleoside transporter family. Oncogene 2013, 32:1714-1723.
20. Chaturvedi P., Singh A.P., Batra S.K. Structure, evolution, and biology of the MUC4 mucin. FASEB J. 2008, 22:966-981.
21. Andrianifahanana M., Moniaux N., Schmied B.M., Ringel J., Friess H., Hollingsworth M.A., Büchler M.W., Aubert J.P., Batra S.K. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin. Cancer Res. 2001, 7:4033-4040.
22. Clevers H., Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205.
23. Clifford R.L., Deacon K., Knox A.J. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta) 1: requirement for Smads, (beta)-CATENIN, and GSK3 (beta). J. Biol. Chem. 2008, 283:35337-35353.
24. Udhayakumar G., Jayanthi V., Devaraj N., Devaraj H. Nuclear translocation of beta-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma. Mol. Cell Biochem. 2011, 357:283-293.
25. Rachagani S., Macha M.A., Ponnusamy M.P., Haridas D., Kaur S., Jain M., Batra S.K. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis 2012, 33:1953-1964.
26. Palacios F., Tushir J.S., Fujita Y., D'Souza-Schorey C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol. Cell Biol. 2005, 25:389-402.
27. Pasca di Magliano M., Biankin A.V., Heiser P.W., Cano D.A., Gutierrez P.J., Deramaudt T., Segara D., Dawson A.C., Kench J.G., Henshall S.M., Sutherland R.L., Dlugosz A., Rustgi A.K., Hebrok M. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One 2007, 2:e1155.
28. Masui T., Hosotani R., Doi R., Miyamoto Y., Tsuji S., Nakajima S., Kobayashi H., Koizumi M., Toyoda E., Tulachan S.S., Imamura M. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Anticancer Res. 2002, 22:4093-4100.
29. Hong S.P., Wen J., Bang S., Park S., Song S.Y. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int. J. Cancer 2009, 125:2323-2331.
30. Swartz M.J., Batra S.K., Varshney G.C., Hollingsworth M.A., Yeo C.J., Cameron J.L., Wilentz R.E., Hruban R.H., Argani P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am. J. Clin. Pathol. 2002, 117:791-796.
31. Kemler R., Hierholzer A., Kanzler B., Kuppig S., Hansen K., Taketo M.M., de Vries W.N., Knowles B.B., Solter D. Stabilization of beta-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast. Development 2004, 131:5817-5824.
32. Mohamed O.A., Clarke H.J., Dufort D. Beta-catenin signaling marks the prospective site of primitive streak formation in the mouse embryo. Dev. Dyn. 2004, 231:416-424.
33. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell. 2009, 17:9-26.
34. Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013, 13:11-26.
35. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?. Nat. Rev. Cancer 2011, 11:254-267.
36. Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. Biochemistry 2013, 153:13-19.
37. Feig C., Gopinathan A., Neesse A., Chan D.S., Cook N., Tuveson D.A. The pancreas cancer microenvironment. Clin. Cancer Res. 2012, 18:4266-4276.
38. Huang C., Huang R., Chang W., Jiang T., Huang K., Cao J., Sun X., Qiu Z. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. Neoplasma 2012, 59:52-61.